Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development

Persistency of neutralizing antibodies depends on titer and interferon-beta preparation

(2011) Harald Hegen et al.   Multiple Sclerosis Journal

Analysis of BAFF and TRAIL expression levels in multiple sclerosis patients: evaluation of expression under immunomodulatory therapy

(2010) A. Kurne et al.   ACTA NEUROLOGICA SCANDINAVICA

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

(2010) Chris H Polman et al.   LANCET NEUROLOGY

Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-β1b

(2010) JS Alexander et al.   Multiple Sclerosis Journal

Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis

(2009) Sabine Cepok   ARCHIVES OF NEUROLOGY

Neutralizing Antibodies to Interferon-β and other Immunological Treatments for Multiple Sclerosis

(2009) Florian Deisenhammer   CNS DRUGS

Identification of new sensitive biomarkers for thein vivoresponse to interferon-β treatment in multiple sclerosis using DNA-array evaluation

(2009) F. Sellebjerg et al.   EUROPEAN JOURNAL OF NEUROLOGY

High-dose intravenous interferon beta in patients with neutralizing antibodies (HINABS): a pilot study

(2009) A Millonig et al.   Multiple Sclerosis Journal

Effect of anti-IFN  antibodies on MRI lesions of MS patients in the BECOME study

(2009) A. R. Pachner et al.   NEUROLOGY

Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis

(2008) Manuel Comabella et al.   CLINICAL IMMUNOLOGY

Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNβ in multiple sclerosis patients

(2008) Regina Lam et al.   JOURNAL OF IMMUNOLOGICAL METHODS

A Biosensor-Based Characterization of the Affinity Maturation of the Immune Response Against Interferon-β and Correlations with Neutralizing Antibodies in Treated Multiple Sclerosis Patients

(2008) Ebrima Gibbs et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Comparative study of four different assays for the detection of binding antibodies against interferon-β

(2008) C Gneiss et al.   Multiple Sclerosis Journal

In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent

(2007) A Sominanda et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY